Also, AIPL1 appears to antagonize NUB1-mediated degradation of FAT10ylated proteins [73], while some pathogenic mutations of AIPL1 are defective in impeding this degradation [72,73], and mutations in NUB1 itself are not found to be associated with LCA [105]. Here, AIPL1 is linked to Leber congenital amaurosis.